Shockwave Reducer Demonstrates Consistent, Positive Results

Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory Angina SANTA CLARA, Calif., April 08, 2024 -- Shockwave Medical, Inc. , a pioneer...

Related Keywords

United Kingdom , De Hoef , Noord Holland , Netherlands , Utrecht , London , City Of , Brompton , Medway , Harefield , Hillingdon , Belgium , United States , Canada , Canadian , Stefan Verheye , Rasha Al Lamee , Debbie Kaster , Michael Foley , Scott Shadiow , Lung Institute , Shockwave Medical Inc , Imperial College , National Heart , University Medical Center Utrecht , Canadian Cardiovascular Society , Exchange Commission , European Union , Nasdaq , Six Month Results , Trial Add , Positive Evidence , Coronary Sinus Reducer , Treat Refractory Angina , Shockwave Reducer , Annual Scientific Sessions , American College , Ranil De Silva , Royal Brompton , Harefield Hospitals , New England Journal , Principal Investigator , Shockwave Coronary Sinus , Shockwave Medical , Intravascular Lithotripsy , Breakthrough Device , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Markets ,